ABEO seems broken out of a downward channel on strong volume and now forming a flag formation. Money flow is very strong. We think it has good upside potential.
Trade Idea
ABEO - Aggressive entry above 3.06 or more conservative entry with break above 3.35. Stop signal 2.77. Target 1 $3.83, Target 2 $4.19
ABEO stock has been beaten down for much of 2019. It had declined by as much as 80% since the beginning of the year. It went on to emerge as one of the biggest gainers in the market yesterday. The company announced that it was going to explore options that could unlock value for the shareholders. It stated that even an outright sale or a takeover is being...
RSI divergence potential reversal confirmation with price action climbing up over the 8EMA with a substantial increase in volume
High Risk: Very much so a hit and run trade given the long term trajectory of the instrument.
Currently ABEONA THERAPEUTICS INC is over sold! I have place a good buy zone to enter in on this stock. I would love to catch this stock under $5 maybe around the $4.50 range. I would suggest buying a few shares now at the current price. If price goes down into the buy zone I would definitely go about buying more.
(Please Comment Your Thoughts Below)
Good looking chart. ABEO has built a bottom with higher lows. Trading over the 50 MA and there is resistance around the 8.50 mark. Support is hard to say but it should not break the latest higher low for the pattern to be strong. Entry point should be around the MA or the break of resistance with higher than average volume.
Recessive Dystrophic Epidermolysis Bullosa (RDEB) is coming very soon, plus AIM Vectors with gene therapy entering into play.
On the technical side we have reached the end of the line for the ABC sequence, from here a very natural flow will take place back towards the highs.
Best of luck
The prices ara pull-backing the 200 weekly simple moving average (SMA). From that prices is possible to assist to a new uptrend wave. Stop loss and target are indicated in the chart. Stay tuned
NASDAQ:ABEO
Today ABEO 2.25% went up $0.40, during the rally it touched the weekly resistance and finally fell after a couple of tries to break through it.Rejection took about an hour, and it showed how eager the buyers were. I have to admit the resistance is strong and now with today's move, it got much stronger. Many attempts but failed. ABEO 2.25% has medium...
ABEO is on my radar as a stock to watch. Recently it broke out of its consolidation range and has come back to retest. The large volume spikes (green) show likely institutional accumulation and I don't think the stock will trade much under $15.00. Watch for a "trip it to rip it" down near $15 and from there I will be looking to take a shot on the long side with...
Abeona Therapeutics Inc. is a clinical-stage biopharmaceutical company developing novel gene therapies for life-threatening rare genetic diseases. The Company’s lead programs include ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene therapy for Sanfilippo syndrome type A (MPS IIIA) and EB-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (RDEB). It is also developing ABO-101 (AAV-NAGLU) for Sanfilippo syndrome type B (MPS IIIB), ABO-201 (AAV-CLN3) gene therapy for juvenile Batten disease (JNCL), ABO-202 (AAV-CLN1) for treatment of infantile Batten disease (INCL), EB-201 for epidermolysis bullosa, ABO-301 (AAV-FANCC) for Fanconi anemia disorder and ABO-302 using a novel CRISPR/Cas9-based gene editing approach to gene therapy for rare blood diseases. The Company also has a plasma-based protein therapy pipeline, including alpha-1 protease inhibitor (SDF Alpha) for inherited COPD, using its proprietary Salt Diafiltration ethanol-free process.
This website uses cookies to ensure you get the best experience on our website. To learn more about cookies, including how to control cookies, please read our Cookies Policy.
ABEO
